Smart Biotech Scientist | Master Bioprocess CMC Development, Biologics Manufacturing & Scale-up for Busy Scientists David Brühlmann: Biotech Entrepreneur & Cell Culture Technology Innovation Aficionado

In this episode, we embark on a journey to uncover the essential strategies for navigating stakeholder relationships in bioprocess CMC development projects.
We delve into the critical role of stakeholders in bioprocess development and how their engagement can determine the success or failure of a project. Drawing from real-life experiences and insights, we explore the importance of understanding stakeholder needs, interests, and power dynamics.
Discover why stakeholder management is not just a skill but an art form essential for unlocking bioprocess success. Join us as we unravel the complexities of stakeholder engagement and provide actionable tips for mastering this crucial aspect of bioprocess development.
Tune in to learn how decoding the dynamics of stakeholder management can lead to triumph in bioprocess projects.
Next Step:
Boost your bioprocess strategy! Book your free assessment for success: https://bruehlmann-consulting.com/assessment

Unlock the secrets to cost-efficient antibody therapeutics with Brian Kelley, Senior Vice President of Process Development at VIR Biotechnology.
In this illuminating episode, industry expert Brian Kelley shares invaluable insights into driving down manufacturing costs while maintaining quality and accessibility. From optimizing batch sizes to maximizing titers, discover practical strategies to streamline the process economics of antibody development.
Key Takeaways:
Scale Matters: Learn how economies of scale play a pivotal role in minimizing manufacturing costs, paving the way for global accessibility of life-saving therapies.Titer Triumphs: Dive deep into the significance of maximizing titers to achieve substantial reductions in batch requirements and cost of goods, revolutionizing antibody production efficiency.Focus Innovation: Gain clarity on where to direct innovation efforts, balancing established manufacturing practices with groundbreaking developments in emerging modalities like cell and gene therapies.Join us as we unravel the future landscape of antibody production, where simplicity and innovation converge to shape the next frontier of healthcare solutions. Tune in now for actionable strategies and visionary perspectives on mastering process economics in antibody therapeutics.
Connect with Brian Kelley:
LinkedIn: https://www.linkedin.com/in/brian-kelley-3389375
Next Step:
Enhance your bioprocess development strategy! Schedule your free assessment to propel your success: https://bruehlmann-consulting.com/assessment

Join us in this enlightening episode as we explore process economics with industry expert Brian Kelley. He is the Senior Vice President of Process Development at VIR Biotechnology.
Unraveling the mysteries of cost management in antibody therapeutics, Brian sheds light on the intricate challenges faced by biotech scientists and engineers.
Key Highlights:
Discover the nuanced interplay between technical and cultural obstacles in process development.Navigate the labyrinth of cost drivers in antibody manufacturing, from raw materials to labor expenses.Learn the art of balancing speed, quality, and cost-effectiveness in bringing therapeutics to market.Tune in for a masterclass in maximizing efficiency and driving down costs in the dynamic landscape of biologics production.
Connect with Brian Kelley:
LinkedIn: https://www.linkedin.com/in/brian-kelley-3389375
Next Step:
Enhance your bioprocess development strategy! Schedule your free assessment to propel your success: https://bruehlmann-consulting.com/assessment

Dive into the future of food with our latest episode, "From Lab to Table: The Science Behind Cultivated Meat." With our guest, Petra Hanga, a Lecturer in Biochemical Engineering at University College London and Chief Scientific Officer of Quest Meat Ltd., we unravel the secrets behind this groundbreaking technology.
Key highlights:

1. Discover how stem cells revolutionize the production of cultivated meat, providing a scalable solution for creating muscle, fat, and connective tissues.

2. Explore the intricate balance of nutrients, growth factors, and environmental conditions crucial for maximizing cell growth and quality.

3. Understand the challenges and breakthroughs in scaling up bioreactor processes for efficient meat production.
Join us for an informative discussion on the cutting edge of food technology. Gain valuable insights into the process of transforming lab-grown cells into delectable dishes on your table.
Don't miss out on this compelling episode!
Connect with Petra Hanga:
LinkedIn: https://www.linkedin.com/in/petrahanga/
Twitter: @PetraHanga
Next Step:
Enhance your bioprocess development strategy! Schedule your free assessment to propel your success: https://bruehlmann-consulting.com/assessment

Dive into the fascinating world of cultivated meat with our guest, Petra Hanga, Lecturer in Biochemical Engineering – Cellular Agriculture at University College London and the Chief Scientific Officer of Quest Meat Ltd.
In this episode, Petra sheds light on the intricacies of developing cultivated meat and reveals the key hurdles biotech scientists face.
Highlights:
Learn how scientists tackle the complexity of replicating animal meat, ensuring a truly authentic taste and texture for future meat alternatives.Gain insight into the innovative solutions shaping the future of sustainable protein sources.Discover the potential of cultivated meat to revolutionize our food system.Join us as we explore the promising landscape of cultivated meat, where science and innovation converge to shape a more sustainable future.
Enjoy your listening!
Connect with Petra Hanga:
LinkedIn: https://www.linkedin.com/in/petrahanga/
Twitter: @PetraHanga
Next Step:
Enhance your bioprocess development strategy! Schedule your free assessment to propel your success: https://bruehlmann-consulting.com/assessment

Does uncovering the secrets of glycan engineering feel like navigating a maze of molecular complexity?
In this captivating continuation of our exploration into the world of glycan engineering, we delve deeper into groundbreaking innovations and the crucial role of analytics in ensuring consistent quality.
Henning von Horsten, Professor of Industrial Bioengineering at HTW Berlin (University of Applied Sciences in Berlin), shares the fascinating story behind a groundbreaking technology designed to modulate antibody-dependent cell-mediated cytotoxicity (ADCC).
You’ll get:
Learn how advancements in high-throughput techniques are streamlining analytics for quicker insights and data-driven optimizations.Explore the future of glycan engineering, which may lead to more effective therapeutics.Understand why glycans matter across various fields of biotechnology, including monoclonal antibodies and vaccines, and discover their pivotal role in shaping the future of healthcare.Connect with Henning von Horsten:
LinkedIn: https://www.linkedin.com/in/henning-von-horsten-b259102/Website: https://lsm.htw-berlin.de/team/prof-dr-rer-nat-hans-henning-von-horsten/Next Step:
Elevate your bioprocess development strategy — Schedule your free assessment now: https://bruehlmann-consulting.com/assessment